Robert A Stewart has an estimated net worth of $20 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., Allergan plc, Actavis, Inc., and CorMedix Inc..

2013 was Robert A Stewart's most active year for acquiring shares with 6 total transactions. Robert A Stewart's most active month to acquire stocks was the month of February. 2013 was Robert A Stewart's most active year for disposing of shares, totalling 9 transactions. Robert A Stewart's most active month to dispose stocks was the month of February. 2013 saw Robert A Stewart paying a total of $6,514,500.00 for 281,699 shares, this is the most they've acquired in one year. In 2013 Robert A Stewart cashed out on 332,165 shares for a total of $26,809,680.74, their largest year based on trade value.